Angiotensin II type 2 receptor gene is not responsible for familial vesicoureteral reflux

被引:22
|
作者
Yoneda, A [1 ]
Cascio, S
Green, A
Barton, D
Puri, P
机构
[1] Univ Coll Dublin, Childrens Res Ctr, Dublin 2, Ireland
[2] Univ Coll Dublin, Natl Ctr Med Genet, Dublin 2, Ireland
[3] Our Ladys Hosp Sick Children, Dublin 12, Ireland
来源
JOURNAL OF UROLOGY | 2002年 / 168卷 / 03期
关键词
vesico-ureteral reflux; genes; angiotensins;
D O I
10.1016/S0022-5347(05)64611-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The renin-angiotensin system has an important role in the development of the kidney and ureter. It has been reported that disruption of the angiotensin II type 2 receptor (AT2) gene leads to congenital anomalies of the kidney and ureter in mice, including vesicoureteral reflux. In humans a single base A to G transition at position -1332 in intron 1 (A-1332G) of the AT2 gene has been reported to occur significantly more often in patients with ureteropelvic junction obstruction and primary obstructive megaureter than in controls. We investigate the incidence of A-1332G transition in patients with primary familial vesicoureteral reflux to determine if AT2 gene is involved in pathogenesis of this disease. Materials and Methods: We evaluated the incidence of A-1332G transition in 82 male and 110 female patients, 111 male and 124 female nonaffected family members from 88 families in which 2 or more members had primary vesicoureteral reflux, and 106 male and 107 female controls with no unselected for reflux status. Genomic DNA was extracted from whole blood samples. Polymerase chain reaction method modified for fluorescent detection was used to type all samples for the A-1332G variant. Furthermore, to identify mutations in the coding sequence of the AT2 gene, we selected 61 patients from different families as well as 15 controls with no vesicoureteral reflux status. Results: The incidence of A-1332G transition in male patients with primary familial vesicoureteral reflux and controls was 33% (27 of 82 patients) and 38% (41 of 106 controls), respectively, and, the incidence of A-1332G substituted allele in female patients and controls was 47% (104 of 220 total alleles) and 50% (107 of 214 total alleles), respectively. Moreover, the transmission/disequilibrium test revealed no significant skewing of genotype transmission from mother to children. None of the 61 patients or 15 controls carried by mutations or polymorphisms in the coding sequence of the AT2 gene. Conclusions: Although the AT2 gene has been reported to have a role in developmental anomalies of the kidney and ureter, our data indicate that it is not involved in the pathogenesis of primary familial vesicoureteral reflux.
引用
收藏
页码:1138 / 1141
页数:4
相关论文
共 50 条
  • [31] TRANSCRIPTIONAL REGULATION OF THE MOUSE ANGIOTENSIN-II TYPE-2 RECEPTOR GENE
    ICHIKI, T
    INAGAMI, T
    HYPERTENSION, 1995, 25 (04) : 720 - 725
  • [32] Angiotensin II Type 2 Receptor: A Novel Target for Prostate Cancer Gene Therapy
    Luo, Jie
    Jie, Feilong
    Pei, Nana
    Zhang, Yangling
    Du, Hongyan
    Li, Jinlong
    Li, Hongwei
    MOLECULAR THERAPY, 2014, 22 : S172 - S172
  • [33] Prevention of cardiac hypertrophy by angiotensin II type-2 receptor gene transfer
    Metcalfe, BL
    Huentelman, MJ
    Parilak, LD
    Taylor, DG
    Katovich, MJ
    Knot, HJ
    Sumners, C
    Raizada, MK
    HYPERTENSION, 2004, 43 (06) : 1233 - 1238
  • [34] Angiotensin II type 2 receptor gene polymorphisms and cardioprotective role in essential hypertension
    Zhang, M
    Ma, H
    Wang, BS
    Zhao, YZ
    HEART AND VESSELS, 2006, 21 (02) : 95 - 101
  • [35] The bradykinin B2 receptor gene is a target of angiotensin II type 1 receptor signaling
    Shen, Bing
    Harrison-Bernard, Lisa M.
    Fuller, Andrew J.
    Vanderpool, Vanessa
    Saifudeen, Zubaida
    El-Dahr, Samir S.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (04): : 1140 - 1149
  • [36] Angiotensin II type 2 receptor gene transfer elicits cardioprotective effects in an angiotensin II infusion rat model of hypertension
    Falcón, BL
    Stewart, JM
    Bourassa, E
    Katovich, MJ
    Walter, G
    Speth, RC
    Sumners, C
    Raizada, MK
    PHYSIOLOGICAL GENOMICS, 2004, 19 (03) : 255 - 261
  • [37] Heteromerisation of the angiotensin II type 1 receptor and the bradykinin type 2 receptor
    Johnstone, Elizabeth K. M.
    Pfleger, Kevin D. G.
    CLINICAL ENDOCRINOLOGY, 2018, 89 : 40 - 40
  • [38] Association of transforming growth factor-β1 gene polymorphism with familial Vesicoureteral reflux
    Kuroda, Seika
    Solari, Valeria
    Puri, Prent
    JOURNAL OF UROLOGY, 2007, 178 (04): : 1650 - 1653
  • [39] The Relation Between Angiotensin Converting Enzyme Gene Polymorphism and Renal Scarring with Vesicoureteral Reflux
    Dumlupmar, Yusuf
    Cankorkmaz, Levent
    Koyluoglu, Gokhan
    Ozdemir, Ozturk
    Guney, Cengiz
    ERCIYES MEDICAL JOURNAL, 2010, 32 (03) : 177 - 182
  • [40] Angiotensin Ii And β2-microglobulin In Urine As Diagnostic Marker Renal Parenchymal Scar In Patients With Vesicoureteral Reflux
    Zaicova, Natalia
    Bernic, Jana
    Ciolac, Victoria
    Sinitcina, Lilia
    Dlin, Vladimir
    Korsunckii, Anatolii
    PEDIATRIC NEPHROLOGY, 2014, 29 (09) : 1784 - 1784